Results-The overall survival probability at five years was 971%, at eight years 76-1%, and at 10 years 62-7% (median survival time 144 months). The impact on survival of the following variables was analysed: age (<20, 21-40, and >40 years), Karnofsky score (80-100, 70, < 70), histology, tumour extension (Ti <3 cm, T2 3-5 cm, T3 > 5 cm maximum diameter), extent of surgical resection (SI radical, S2 subtotal <10% residual tumour, S3 partial-10%/o-50% residual tumour), and radiotherapy (either performed or not). A significant positive association with survival at univariate analysis was found for the age group <20 years (P = 0.003), for total and subtotal surgical resections (Si and S2; P < 0-001) and for the non-irradiated patients (P = 0.0049), whereas a shorter survival probability was noticed for gemistocytic astrocytomas (P < 0-001) and for tumour extension >5 cm (T3; P = 0.0193). Karnofsky performance did not show any significant association with survival. The most relevant factor affecting survival at the multivariate analysis was the extent of surgical resection, which resulted as the only variable retaining a significant value (P = 0-001, risk factor = 2.20).
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Conclusions-The data strongly support the role of a surgical removal as extensive as possible in the treatment of these tumours. (7 Neurol Neurosurg Psychiatry 1996;61:291-296) Keywords: low grade glioma; prognostic factor; surgery
The obvious optimal purpose of treatment is to cure the patient by suppressing the disease. This goal is unfortunately very rarely achieved when dealing with cerebral neuroepithelial tumours. In most of these cases it is necessarily limited to offering the longest and best quality survival, without producing or further increasing neurological deficits. Within these limitations, resective surgery is generally regarded as the most fruitful means of treatment, even if in several cases it is the first step of a multimodality management. Even if the tumour cannot be completely eradicated, a substantial reduction of its mass can be achieved, thus enhancing the efficacy of other subsequent treatments, such as radiotherapy or chemotherapy.
For low grade gliomas, however, the utility of surgical resection has been questioned.'-'0 Uncertainties regarding their natural history and the possibility of long survival in untreated cases are at the basis of the controversy. The purpose of the present study was The end point of the study was the surgical outcome in terms of survival. Survival data were obtained from clinical charts, and were recorded as the time from surgery to death or latest follow up examination. All deaths but one were directly related to the cerebral tumour. Some of the possible factors affecting survival were also evaluated. Among these we selected age and presurgical Kamofsky score as factors related to the patients, histology, and tumour extension as related to the tumour characteristics, and extent of surgical resection and radiotherapy as related to the treament ( this varied with the opinion of the surgeon and the radiotherapist referred to; it was performed on 49 patients, in 29 (59 2%) immediately after surgery, and in the remaining 20 (40 8%) at tumour regrowth or progression. A telecobalt unit or a linear accelerator were used to deliver 50-60 Gy target dose in daily fractions of 1 8 Gy, five fractions a week.
The period of clinical observation after surgery ranged from 48 to 192 months. The mean follow up of the living patients was 97-02 (SD 52-81) months (median 93 months, range 24-190 months) . No patient of this series was lost to follow up.
STATISTICAL ANALYSIS
Survival estimates were computed according to the Kaplan-Meyer product-limit method'2 and differences in survival were compared with the log rank test for censored data.3 14 A proportional hazard regression analysis (Cox model)'5 was used to determine the effect of different variables on survival (stepwise selection: enter limit at P < 0 1, remove limit at P > 0-15 Karnofsky score with survival was found in our series (P = 0-8187 and P = 0-0966 respectively; fig 3A and B) .
Tumour relatedfactors
Histology- Figure 4 shows the relation between tumour histology and survival. Survival curves showed a highly significant difference between the gemistocytic astrocytomas and all the other three histological types (P < 0-001), the first being associated with a lower survival probability (median survival time 77 months, censored 33 3%). No significant differences were found among the other three (P = 0 27 1). Tumour size-No significant differences in survival were found by comparing simultaneously the three groups (P = 0 14). A significant difference became apparent (P = 0-0193) when considering the group with tumour diam- ties were found in the S1 group (mean survival time not reached, censored 80%); shorter survivals were found for partial tumour removals (S3 group: median survival time 96 months, censored 42 9%). Postsurgical radiotherapy-As illustrated in fig 7 a significant difference appeared in the late part of the survival curves. It indicates a surprising better outcome in the non-irradiated patients (P = 00049). However, these differences between the survival of the irradiated (mean survival time not reached, censored 81 6%) and non-irradiated patients (mean survival time 108 months, censored 53-4%) disappear if the gemistocytic astrocytomas (all of which were irradiated) are excluded (P = 0346). 
Treatment relatedfactors
Extent of surgical resection-The association of the extent of tumour removal with the survival probability was highly significant (P < 0001; fig 6) . Significance was retained when comparing the subtotal (S2) and partial (S3) resection groups (P = 0 005). By contrast, it was lost when comparing radical and subtotal resections (P = 0-319). Longer survival probabili- 
the surgical technique contributed to this improvement. Thirdly, all our grade II cases showing even a minor focus of anaplasia were excluded. Fourthly, biopsy was not considered, because of its obvious diagnostic, but not therapeutic purpose.
The age of the patient at the time of surgery, the tumour histology (G), and extension (T), as well as the extent of surgical resection of the tumour were the most significant factors affecting survival in the univariate analysis of our series of grade II hemispheric gliomas. The multivariate analysis showed that the extent of tumour resection (S) was overwhelming, being the only variable retaining a significant value. The presurgical and postsurgical performance status, as expressed by the Karnofsky score was not significantly associated with survival. The role of radiotherapy was not clear.
The role of the extent of surgical resection in influencing survival of the low grade gliomas was recognised in previous studies, 1621 23-31 33 3638 but it was not supported by others.'-'0 To our knowledge, our study is the first one showing it not only as relevant, but as the most relevant factor affecting survival. Its positive value is strengthened by the relatively low early mortality (1-5%) and, above all, by the low incidence (11 6%) and low degree of worsening of neurological status (minimum postoperative Kamofsky score: 0 60), coupled with its improvement in 37-7% of our patients. It has to be remembered that a higher probability of a better score is expected after complete tumour removal, as stressed by the linear regression analysis. Obviously, the finding of the pre-eminent relevance of the tumour resection is valid only within the limits of our research approach. In particular, its value is dependent on the reliability of the criteria followed to estimate it. In the pre-CT era, the only criterion was the surgeon's impression at the time of surgery. Once modem neuroimaging became available, it was realised how fallacious such a criterion may be. The comparison between presurgical and postsurgical CT 34 The criteria that prompted us in to consider radiotherapy in some cases were the documented incompleteness of the resection or the evidence of tumour regrowth or progression. But we have to admit that these criteria, especially the first one, were not rigid, reflecting our uncertainties for what concerns the gemistocytic astrocytomas. The lack of significant association of the presurgical and postsurgical Kamofsky score with survival in our series contrasts with most of the others 2 
